185 related articles for article (PubMed ID: 17537052)
1. [Adjuvant interferon therapy in malignant melanoma].
Mohr P
J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
[No Abstract] [Full Text] [Related]
2. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
3. [Adjuvant interferon treatment of melanoma].
Török L
Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
[TBL] [Abstract][Full Text] [Related]
4. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
5. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
Kimyai-Asadi A; Usman A
J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
8. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
9. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
10. [Clinical studies with sorafenib (Nexavar) in metastatic melanoma].
Hauschild A
J Dtsch Dermatol Ges; 2007 Apr; 5(4):345. PubMed ID: 17376105
[No Abstract] [Full Text] [Related]
11. [Interferon: therapy in patients with cutaneous malignant melanoma in adjuvant setting].
Wcisło G; Szczylik C
Pol Merkur Lekarski; 2003 Jul; 15(85):5-8. PubMed ID: 14593950
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy of cutaneous melanoma.
Ascierto PA; Palmieri G
Lancet; 1999 Jan; 353(9149):328. PubMed ID: 9929057
[No Abstract] [Full Text] [Related]
13. [Dermatological Association of Oncology (ADO)].
Trefzer U
J Dtsch Dermatol Ges; 2008 Oct; 6(10):899. PubMed ID: 18992034
[No Abstract] [Full Text] [Related]
14. Noninterferon-based adjuvant therapy for high-risk melanoma.
Spitler LE
Expert Rev Anticancer Ther; 2002 Oct; 2(5):547-62. PubMed ID: 12382523
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for proper use of antineoplastic agents. Skin cancer].
Uhara H; Saida T
Gan To Kagaku Ryoho; 2002 Jun; 29(6):1074-80. PubMed ID: 12109448
[No Abstract] [Full Text] [Related]
16. Adjuvant interferon in melanoma: is duration of therapy important?
McArthur GA
J Clin Oncol; 2014 Jan; 32(3):171-3. PubMed ID: 24344216
[No Abstract] [Full Text] [Related]
17. Where are we going with regional therapy for melanoma?
Tyler D
Ann Surg Oncol; 2004 May; 11(5):455-7. PubMed ID: 15078631
[No Abstract] [Full Text] [Related]
18. [Adjuvant drug therapy of malignant melanoma. Current knowledge and multi-center studies in German-speaking countries].
Hauschild A; Volkenandt M; Garbe C
Dtsch Med Wochenschr; 2000 Oct; 125(42):1272-8. PubMed ID: 11098240
[No Abstract] [Full Text] [Related]
19. Adjuvant therapy for cutaneous melanoma.
Nathan FE; Mastrangelo MJ
Semin Oncol; 1995 Dec; 22(6):647-61. PubMed ID: 8539640
[No Abstract] [Full Text] [Related]
20. Adjuvant high-dose interferon therapy for melanoma: nothing has really changed.
Sanchez-Muñoz A; Navarro-Perez V; Alonso L; Moreno I; Alba E
Melanoma Res; 2014 Oct; 24(5):522-3. PubMed ID: 25185694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
